# Robot-assisted corpo-caudal pancreatectomy and splenectomy for pancreatic acinar cell carcinoma: a case report

## TL;DR

A 78-year-old man with a rare pancreatic tumor underwent robot-assisted surgery, resulting in successful tumor removal and a smooth recovery.

## Contribution

This case report presents the first use of robot-assisted surgery for acinar cell carcinoma of the pancreas.

## Key findings

- Robot-assisted surgery enabled precise tumor resection with minimal blood loss.
- Postoperative follow-up showed no recurrence or metastasis at three and six months.
- The procedure preserved critical structures and resulted in an uneventful recovery.

## Abstract

Acinar cell carcinoma of the pancreas (ACCP) is an exceptionally rare malignancy, accounting for <1% of all exocrine pancreatic tumors. This case report describes a 78-year-old male presenting with abdominal pain, weight loss, and anorexia, diagnosed with a tumor in the pancreatic body through imaging and biopsy. The patient underwent a robot-assisted corpo-caudal pancreatectomy and splenectomy using the Da Vinci system. This approach enabled precise resection with minimal blood loss and preservation of critical structures. Histopathology confirmed a well-differentiated acinar cell carcinoma with tumor-free margins. The postoperative course was uneventful, and follow-up imaging at three and six months demonstrated no recurrence or metastasis. This case underscores the advantages of robotic-assisted surgery, including enhanced precision, reduced complications, and optimized recovery, highlighting its role as a transformative tool for managing complex pancreatic tumors like ACCP.